Immunotherapy Drugs Market by Drug Type (Adult Vaccines, Monoclonal Antibodies, Checkpoint Inhibitors, Interleukins, Interferon Alpha & Beta, and Others), by Therapeutic Application (Autoimmune & Inflammatory Diseases, Cancer, Infectious Diseases, and Others), and by End-User (Hospitals, Clinics, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018—2025

Global immunotherapy drugs market expected to generate around USD 330.4 billion by 2025, at a CAGR of around 13.24% between 2019 and 2025. Immunotherapy, also referred to as biological therapy, uses the body’s natural defense system to fight cancer cells and other infections.

28-Jan-2019 | Number of pages: 110 | Report Code: ZMR-1811 | Report Format : | Status : Published

Abstract

The report covers a forecast and an analysis of the immunotherapy drugs market on a global and regional level. The study provides historical data from 2016, 2017, and 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes drivers and restraints for the immunotherapy drugs market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the immunotherapy drugs market on a global and regional level.

In order to give the users of this report a comprehensive view of the immunotherapy drugs market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Immunotherapy Drugs Market

The report provides company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the immunotherapy drugs market on a global and regional basis.

The study provides a decisive view of the immunotherapy drugs market by segmenting the market based on drug type, therapeutic applications, end-user, and region. By drug type, the market is segmented into adult vaccines, monoclonal antibodies, checkpoint inhibitors, interleukins, interferon alpha and beta, and others. Preventive vaccines and therapeutic vaccines comprise the adult vaccines segment. By therapeutic application, this global market is segmented into autoimmune and inflammatory diseases, cancer, infectious diseases, and others. Cancer segment is further divided into the solid tumor and malignant. Hospitals, clinics, and others form the end-user segment of the global immunotherapy drugs market.

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further divided into major countries including the U.S. Canada, Germany, France, the UK, China, Japan, India, and Brazil.

Some key players of the immunotherapy drugs market include F. Hoffmann-La Roche AG, Amgen, Inc., Novartis International AG, AbbVie, Inc., Merck & Co., Inc., GlaxoSmithKline, Eli Lilly and Company, Bristol-Myers Squibb, AstraZeneca plc, and Johnson & Johnson, among others.

This report segments the global immunotherapy drugs market into:

Global Immunotherapy Drugs Market: By Drug Type

  • Monoclonal Antibodies
  • Adult Vaccines
    • Preventive Vaccines
    • Therapeutic Vaccines
  • Checkpoint Inhibitors
  • Interferons Alpha and Beta
  • Interleukins
  • Others

Global Immunotherapy Drugs Market: By Therapeutic Application

  • Cancer
    • Solid Tumor
    • Malignant
  • Autoimmune and Inflammatory Diseases
  • Infectious Diseases
  • Others

Global Immunotherapy drugs Market: By End-User

  • Hospitals
  • Clinics
  • Others

Global Immunotherapy Drugs Market: By Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Related Reports

Rheumatoid Arthritis Drugs Market by Drug Type (NSAID’s, Analgesics, DMARD’s, Glucocorticoids, Biologics, and Others) and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, and Online Sales): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Apr-2019 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3999 | Report Format:

The report covers a forecast and an analysis of the rheumatoid arthritis drugs market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes drivers and restraints of the rheuma...Read More

Pharmaceutical Vials Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026

Price : $ 3999.00 | Report Code: ZMR-3985 | Report Format:

Global Pharmaceutical Vials Market: Overview Pharmaceutical vials are a type of small containers that are used for the purpose of storing liquid medications. They are made up of plastic or glass and are mainly used for unit dose packaging of medications. Pharmaceutical vials also help patients i...Read More

Immuno Oncology Assays Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026

Price : $ 3999.00 | Report Code: ZMR-3963 | Report Format:

Global Immuno Oncology Assays Market: Overview Immuno Oncology Assays are used when testing immunotherapies as it is often critical to assess thefunctional cytotoxicity and infiltration capacity. In addition, Immunomodulators effects of these new drugs in combination with already approved ones n...Read More

Drug Integrated Polymer Fibers Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026

Price : $ 3999.00 | Report Code: ZMR-3933 | Report Format:

Global Drug Integrated Polymer Fibers Market: Overview Drug integrated polymers fibers are generally made from biodegradable and biocompatible materials such as poly lactic acid and its derivatives such as PLLA, polydioxanone, polycaprolactone, polyglycolic acid, poly(lactic-co-glycolic acid), a...Read More

Gynecological Drugs Market by Therapeutics (Hormonal Therapy and Non-Hormonal Therapy), by Indication (Gynecology Cancers, Endometriosis, Female Infertility, Menopausal Disorder, Gynecology Infections, Polycystic Ovary Syndrome, Contraception (Birth Control), and Others), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Mar-2019 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3926 | Report Format:

The report covers a forecast and an analysis of the gynecological drugs market on a global and regional level. The study provides historical data for 2016, 2017, and 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints of the gyneco...Read More

Download Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.